Top Abstract Purchase Related
Home
>
Node
>
Subnode

Atenolol in hypertension: follow-up of patients crossed over to this agent from propranolol, pindolol or metoprolol

Frewin, D.B.; Penhall, R.K.; Leonello, P.P.; Clapp, R.J.

New Zealand Medical Journal 92(672): 389-390

1980

ISSN/ISBN: 0028-8446
PMID: 6937768
Document Number: 160947
Thirty hypertensive patients treated with a drug regimen which contained a beta-receptor antagonist (either propranolol, pindolol or metoprolol) exhibited an improvement in blood pressure control when atenolol was substituted for the corresponding beta-blocker in the drug regimen. Additional benefits noted were a reduction in concomitant drug therapy and an improvement in reported side effects. Atenolol caused a significant decrease in heart rate in the group for which the mean follow-up period was 23.6 months.

Document emailed within 1 workday
Secure & encrypted payments

England, J.D. 1981: Beta adrenoreceptor-blocking drugs once daily in essential hypertension: a comparison of propranolol, pindolol and atenolol Australian and New Zealand Journal of Medicine 11(1): 35-40
Niedermayer, W.; Seiler, K.U.; Wassermann, O. 1978: Pharmacokinetics of antihypertensive drugs (atenolol, metoprolol, propranolol and clonidine) and their metabolites during intermittent haemodialysis in humans Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association 15: 607-609
Lazebnik, L.B.; Mikheeva, O.M.; Drozdov, V.N.; Petrakov, A.V.; Sil'vestrova, S.I. 2008: Atenolol and metoprolol differentiated therapy of patients with arterial hypertension complicated by pathology of the digestive tract organs Eksperimental'naia i Klinicheskaia Gastroenterologiia 2: 22-26
Epstein, S.E.; LUbbe, W.F. 1977: Effects of propranolol and atenolol on blood pressure and plasma renin activity in patients with moderate hypertension South African Medical Journal 52(22): 875-879
Jaillon, P.; Hecklé, J.; Weissenburger, J.; Cheymol, G. 1980: Cardiac electrophysiologic properties of dl-propranolol, d-propranolol, l-propranolol and dl-pindolol in anesthetized dogs Journal of Pharmacology and Experimental Therapeutics 212(2): 347-353
Bosman, A.R.; Goldberg, B.; McKechnie, J.K.; Offermeier, J.; Oosthuizen, O.J. 1977: South African multicentre study of metoprolol and propranolol in essential hypertension South African Medical Journal 51(3): 57-61
Telatyńska-Smieszek, B.ła. 2002: Pharmacokinetic comparison of propranolol and atenolol in people with primary hypertension Annales Academiae Medicae Stetinensis 48: 367-380
Hardin, J.M.; Andrejak, M.; Makdassi, R.; Gherbrand, J.D.; Fievet, P.; Schmit, J.L.; Roger, J.C.; Harichaux, P.; Kassouf, J.; Fournier, A. 1981: Control of hypertension and blood lactate during exercise. Comparison of central antihypertensive agents with the cardio-selective beta blockers metoprolol and atenolol Archives des Maladies du Coeur et des Vaisseaux 74(Special Issue): 117-124
Hansson, L.; Henningsen, N.C.; Jameson, S.; Karlberg, B.E.; Westerlund, A.; Aberg, H. 1976: Clinical testing of a new beta blocking agent--atenolol--in hypertension Lakartidningen 73(34): 2741-2744
Shen, J.Q. 1981: Atenolol, a new beta-adrenergic blocking agent, in treatment of hypertension: therapeutic effect and hemodynamic changes Zhonghua Xin Xue Guan Bing Za Zhi 9(2): 94-98
Beumer, H.M.; Teirlinck, C.; Wiseman, R.A. 1978: Comparative investigation of the respiratory and cardiovascular effect of mepindolol, propranolol and pindolol in asthmatic patients International Journal of Clinical Pharmacology and Biopharmacy 16(6): 249-253
Webster, J.; Petrie, J.C.; Robb, O.J.; Witte, K.; Lovell, H.G. 1987: Atenolol or propranolol in hypertensive patients poorly controlled on captopril and frusemide Journal of Human Hypertension 1(2): 121-126
Edwards, K.G.; Tweed, J.A.; Saul, P.A.; Wright, F.W. 1986: A comparative study of atenolol/nifedipine and atenolol/diuretic in hypertension Pharmatherapeutica 4(10): 637-641
Tötterman, K.J.; Groop, L.C. 1982: No effect of propranolol and metoprolol on tolbutamide-stimulated insulin-secretion in hypertensive diabetic and non-diabetic patients Annals of Clinical Research 14(4): 190-193
Dorow, P.; Weiss, T.; Felix, R.; Schmutzler, H. 1984: The influence of propranolol, metoprolol, and mepindolol on mucociliary clearance in coronary heart disease patients without pulmonary disease International Journal of Clinical Pharmacology Therapy and Toxicology 22(2): 108-111
Sergi, M.; Palermo, A.; Renesto, E.; Vetrò, A.; Sega, R.; Bosisio, E. 1979: Effect of propranolol and pindolol on the ventilatory response to carbonic anhydride Minerva Anestesiologica 45(4): 205-210
Ilyas, M.; Jafary, M.H.; Peracha, M.A.; Janjua, M.; Khan, N. 1975: Double blind trial of propranolol and pindolol in angina pectoris Jpma. Journal of the Pakistan Medical Association 25(7): 165-166
Potempa, K.M.; Fogg, L.F.; Fish, A.F.; Kravitz, H.M. 1993: Blood pressure reactivity in the evaluation of resting blood pressure and mood responses to pindolol and propranolol in hypertensive patients Heart and Lung: the Journal of Critical Care 22(5): 383-391
Tkaczewski, W.; Goch, J.H.; Wichan, P.; Kowalski, J. 1980: Ergometric test in sympatheticotonia after administration of propranolol, pindolol, verapamil and oxazepam Polski Tygodnik Lekarski 35(23): 867-869
Gajewska, M.; Glass, G.; Kostelecki, J. 1992: Spectrofluorometric analysis of propranolol and atenolol Acta Poloniae Pharmaceutica 49(3): 1-4